Home / Centerstage / 2015 / June / Week 1 /
A panel of advisors to the US Food and Drug Administration (FDA) recommends the approval of flibanserin, a drug aimed at improving a woman's libido, with an 18-6 vote. This recommendation sparks discussions around the need for female-specific treatments for sexual desire disorders and raises questions about the balance between medical intervention and individual autonomy in matters of sexual health.
Tuesday, 2 June, 2015